Literature DB >> 23648547

Oral administration of the CCR5 inhibitor, maraviroc, blocks HIV ex vivo infection of Langerhans cells within the epithelium.

Takamitsu Matsuzawa1, Tatsuyoshi Kawamura2, Youichi Ogawa1, Masaaki Takahashi3, Rui Aoki1, Kohji Moriishi4, Yoshio Koyanagi5, Hiroyuki Gatanaga6, Andrew Blauvelt7, Shinji Shimada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23648547     DOI： 10.1038/jid.2013.215

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  3 in total

Review 1.  The role of human dendritic cells in HIV-1 infection.

Authors:  Zahra Ahmed; Tatsuyoshi Kawamura; Shinji Shimada; Vincent Piguet
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

2.  Topical pimecrolimus inhibits high-dose UVB irradiation-induced epidermal Langerhans cell migration, via regulation of TNF-α and E-cadherin.

Authors:  ZhiQiang Yin; JiaLi Xu; BingRong Zhou; Di Wu; Yang Xu; JiaAn Zhang; Dan Luo
Journal:  Drug Des Devel Ther       Date:  2014-10-10       Impact factor: 4.162

Review 3.  Maraviroc: a review of its use in HIV infection and beyond.

Authors:  Shawna M Woollard; Georgette D Kanmogne
Journal:  Drug Des Devel Ther       Date:  2015-10-01       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.